Abbott Laboratories (ABT) on Tuesday reported adjusted earnings of $ 1.32 per share on $ 10.5 billion in sales for the first quarter. In response, ABT shares fell.
X
Analysts at Zacks Investment Research expected Abbott to earn $ 1.33 per share on $ 10.84 billion in sales.
In the previous year, Abbott earned 65 cents a share and reported sales of $ 7.73 billion.
For the year ending 2021, the healthcare business still sees an adjusted earnings of at least $ 5 per share. Analysts are asking for adjusted earnings of $ 5.07 per share and $ 42.43 billion in sales.
In the stock market pre-trading, ABT shares fell 3.2% to 120.53. Shares currently form a flat base with a buying point at 128.64, according to MarketSmith.com.
More to follow.
Follow Allison Gatlin on Twitter @IBD_AGatlin.
YOU MAY ALSO LIKE THIS:
GlaxoSmithKline boasts report Activist investor takes a significant stake
Thermo expands its largest business with $ 17.4 billion PPD buyout
See shares on the list of leaders near a buyout
Review IBD’s investment strategies for relevant market insights
Find the best long-term investments with IBD leaders